Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis.
about
Synergistic antitumor effects of CDK inhibitor SNS‑032 and an oncolytic adenovirus co‑expressing TRAIL and Smac in pancreatic cancerOncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies.Recombinant adenovirus IL-24-Bax promotes apoptosis of hepatocellular carcinoma cells in vitro and in vivo.Melanoma differentiation associated gene-7/interleukin-24 potently induces apoptosis in human myeloid leukemia cells through a process regulated by endoplasmic reticulum stress.Myeloid cells migrate in response to IL-24.Species D adenoviruses as oncolytics against B-cell cancers.ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells.Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC.Downregulation of Mcl-1 synergizes the apoptotic response to combined treatment with cisplatin and a novel fiber chimeric oncolytic adenovirusCD47-retargeted oncolytic adenovirus armed with melanoma differentiation-associated gene-7/interleukin-24 suppresses in vivo leukemia cell growthArmed replicating adenoviruses for cancer virotherapy."Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo.Marine Lectins DlFBL and HddSBL Fused with Soluble Coxsackie-Adenovirus Receptor Facilitate Adenovirus Infection in Cancer Cells BUT Have Different Effects on Cell SurvivalTriptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*.Homoharringtonine acts synergistically with SG235-TRAIL, a conditionally replicating adenovirus, in human leukemia cell lines.Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy.Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers.Targeting eradication of chronic myeloid leukemia using chimeric oncolytic adenovirus to drive IL-24 expression.Cost-effective production of recombinant human interleukin 24 by lactose induction and a two-step denaturing and one-step refolding method.Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice.A conditionally replicating adenovirus carrying interleukin-24 sensitizes melanoma cells to radiotherapy via apoptosis.Augmentation of adenovirus 5 vector-mediated gene transduction under physiological pH conditions by a chitosan/NaHCO3 solution.Inhibition of autophagy induced by overexpression of mda-7/interleukin-24 strongly augments the antileukemia activity in vitro and in vivo.The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers.Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene.A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy.The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
P2860
Q33702030-80FA85A0-5C70-4DE3-84C5-1754463CF8FDQ33713735-944D69C9-6E59-40DE-95A4-7AAE55E3C27CQ34238776-84BA0FBE-6494-4FA7-8FC2-53D430F181FBQ34359570-DB3B9154-7F31-4458-AFB9-482B6E2C3ABDQ35141406-09BF8994-8D03-4C84-9FBE-745EC3B99B13Q35511348-10383B46-46D7-4324-A23B-5DFE343F7042Q35686509-582C5781-13B1-49BB-871D-34E5502A0E50Q36612167-F2A1D1DC-0AE5-48A8-BB4D-F52BA62C1312Q36642630-2E5B6990-C8D9-445D-8104-182935CAFC0DQ36685435-6B81FA2F-9D70-487E-91E3-39F2421B1907Q37386616-8FB29058-196B-49F8-8C88-8A6571C1A6E2Q37622288-9FA55EEC-0EF2-42BA-A9C5-F60F03826E54Q37679277-C822A6BE-1D2E-4783-808A-758515444B36Q37721826-06628EFB-A6D5-4A2A-B806-A55187A09055Q37727428-11049D11-386B-447A-803A-95AF269C8D9CQ37729281-AC00FEAB-1D5F-46D6-B746-2A70DEFF1834Q37733550-CF412979-DC43-42ED-802E-992F948C9FE3Q37867584-3F93DC6D-A759-41CC-9924-3307FFECC36EQ37945288-A85C3211-FE29-440A-A203-6534F43FAC36Q38073096-16767060-3315-4317-A027-6BF0333FBAD6Q38861342-0E5A253D-A819-4542-A6A6-CA3DBA9B0AF8Q39068573-A72D60C7-E37F-4EA1-86D7-CAC1044FBEE3Q39153193-693993BF-90F2-4A06-A43F-292E797C7880Q39336014-177E1967-69E3-4907-8EA7-9371AE017136Q39649787-BB839FE2-DAF3-46B6-825D-CD54557D1C00Q39803694-AB266496-F4BA-4508-942D-709E7C9F4235Q40182196-B6AFF145-1BA5-402D-AB74-5141A6472A73Q45358201-1DF86CB3-22F8-487A-8D3E-749CAF54C708Q49963933-69F4545C-C81D-46E8-B439-1463494D9CBCQ57177485-A69B1E17-7B4A-4850-984B-87D652ED20E9
P2860
Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Enhanced antitumor activity by ...... ia via induction of apoptosis.
@en
type
label
Enhanced antitumor activity by ...... ia via induction of apoptosis.
@en
prefLabel
Enhanced antitumor activity by ...... ia via induction of apoptosis.
@en
P2093
P2860
P356
P1433
P1476
Enhanced antitumor activity by ...... ia via induction of apoptosis.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2405034
P577
2007-11-29T00:00:00Z
P5875
P6179
1025788614